251 related articles for article (PubMed ID: 9154872)
41. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM
Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562
[TBL] [Abstract][Full Text] [Related]
42. Imaging fibrosing alveolitis.
Strickland B
Postgrad Med J; 1988; 64 Suppl 4():35-40. PubMed ID: 3076932
[TBL] [Abstract][Full Text] [Related]
43. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
Hubbard R; Venn A; Lewis S; Britton J
Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
[TBL] [Abstract][Full Text] [Related]
44. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
[TBL] [Abstract][Full Text] [Related]
45. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis.
du Bois RM; Wells AU
Eur Respir J Suppl; 2001 Sep; 32():43s-55s. PubMed ID: 11816824
[TBL] [Abstract][Full Text] [Related]
46. Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis.
Baughman RP; Shipley RT; Loudon RG; Lower EE
Chest; 1991 Jul; 100(1):96-101. PubMed ID: 2060395
[TBL] [Abstract][Full Text] [Related]
47. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
48. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.
Haslam PL; Cromwell O; Dewar A; Turner-Warwick M
Clin Exp Immunol; 1981 Jun; 44(3):587-93. PubMed ID: 7326869
[TBL] [Abstract][Full Text] [Related]
49. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis.
Wells AU; Hansell DM; Harrison NK; Lawrence R; Black CM; du Bois RM
Eur Respir J; 1993 Jun; 6(6):797-802. PubMed ID: 8339797
[TBL] [Abstract][Full Text] [Related]
50. Capsaicin induced cough in cryptogenic fibrosing alveolitis.
Doherty MJ; Mister R; Pearson MG; Calverley PM
Thorax; 2000 Dec; 55(12):1028-32. PubMed ID: 11083888
[TBL] [Abstract][Full Text] [Related]
51. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
[TBL] [Abstract][Full Text] [Related]
53. Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: a combined CT and scintigraphic study.
Strickland NH; Hughes JM; Hart DA; Myers MJ; Lavender JP
AJR Am J Roentgenol; 1993 Oct; 161(4):719-25. PubMed ID: 8372745
[TBL] [Abstract][Full Text] [Related]
54. Asbestosis and cryptogenic fibrosing alveolitis: a radiological and functional comparison.
Cookson WO; Musk AW; Glancy JJ
Aust N Z J Med; 1984 Oct; 14(5):626-30. PubMed ID: 6597709
[TBL] [Abstract][Full Text] [Related]
55. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
[TBL] [Abstract][Full Text] [Related]
56. Mediastinal lymphadenopathy in cryptogenic fibrosing alveolitis: the effect of steroid therapy on the prevalence of nodal enlargement.
Franquet T; Gimenez A; Alegret X; Rodriguez-Arias JM
Clin Radiol; 1998 Jun; 53(6):435-8. PubMed ID: 9651059
[TBL] [Abstract][Full Text] [Related]
57. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.
Nicholson AG; Colby TV; du Bois RM; Hansell DM; Wells AU
Am J Respir Crit Care Med; 2000 Dec; 162(6):2213-7. PubMed ID: 11112140
[TBL] [Abstract][Full Text] [Related]
58. Fibrosing alveolitis: CT-pathologic correlation.
Müller NL; Miller RR; Webb WR; Evans KG; Ostrow DN
Radiology; 1986 Sep; 160(3):585-8. PubMed ID: 3737898
[TBL] [Abstract][Full Text] [Related]
59. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
Hubbard R
Eur Respir J Suppl; 2001 Sep; 32():119s-121s. PubMed ID: 11816818
[TBL] [Abstract][Full Text] [Related]
60. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.
Daniil ZD; Gilchrist FC; Nicholson AG; Hansell DM; Harris J; Colby TV; du Bois RM
Am J Respir Crit Care Med; 1999 Sep; 160(3):899-905. PubMed ID: 10471616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
